Related Experiment Video

Updated: Dec 30, 2025

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

11.2K

Iron Packaging Regulations in the United States and Pediatric Morbidity: A Retrospective Cohort Study

James B Leonard1, Elizabeth Quaal Hines1, Wendy Klein-Schwartz1

  • 1University of Maryland, Baltimore, MD, USA.

Clinical Pediatrics
|January 25, 2020
PubMed

Insights

Despite relaxed iron packaging rules, severe pediatric iron exposures decreased. This study found fewer markers of severity and less deferoxamine use after regulations changed, indicating improved child safety outcomes.

Area of Science:

  • Toxicology
  • Pediatric Health
  • Public Health Policy

Background:

  • Iron poisoning is a significant cause of illness and death in children.
  • Previous regulations mandated strict unit-dose packaging for iron supplements to mitigate risks.

Purpose of the Study:

  • To determine if the removal of strict iron packaging requirements in 2003 led to increased pediatric iron poisoning.
  • To analyze trends in iron-related morbidity and mortality in children post-regulation change.

Main Methods:

  • Retrospective cohort study using the National Poison Data System (2000-2017).
  • Inclusion criteria identified 4110 pediatric iron exposures.
  • Comparison of outcomes before (2000-2003) and after (2004-2017) the removal of packaging regulations.

Main Results:

  • The incidence of any marker of severity was lower after regulation removal (3.8% vs 7.2%).
  • Deferoxamine use, an indicator of severe poisoning, was also less frequent post-regulation removal (1.0% vs 2.6%).
  • No significant difference was observed in the frequency of critical serious effects like acidosis, elevated transaminases, or hypotension.

Conclusions:

  • The removal of strict iron packaging regulations in the U.S. did not result in an increase in severe pediatric iron exposures.
  • The trend of decreasing severe iron exposures in children has continued despite regulatory changes.
  • This suggests other factors may be contributing to the decline in severe iron poisoning cases.

Keywords:
National Poison Data Systemdeferoxaminemultivitaminspoison control centersupplement

More Related Videos

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
151
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
165
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
198
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K